7 results
10-K
2023 FY
APGE
Apogee Therapeutics, Inc.
5 Mar 24
Annual report
6:15am
in Figure 6 below.
Figure 6 — Our half-life extended mAbs are designed to be recycled back into circulation more readily so drug exists at much higher
DRS
APGE
Apogee Therapeutics, Inc.
9 Feb 24
Draft registration statement
12:00am
is shown in Figure 6 below.
Figure 6 — Our half-life extended mAbs are designed to be recycled back into circulation more readily so drug exists
424B4
APGE
Apogee Therapeutics, Inc.
17 Jul 23
Prospectus supplement with pricing info
4:08pm
.
Figure 6 — Our half-life extended mAbs are designed to be recycled back into circulation more readily so drug exists at much higher levels
S-1
APGE
Apogee Therapeutics, Inc.
22 Jun 23
IPO registration
4:19pm
extended mAbs are designed to be recycled back into circulation more readily so drug exists at much higher levels for longer duration of effect
This natural
DRS/A
nuy8n2nj8w8aexl3w1wy
5 Jun 23
Draft registration statement (amended)
12:00am
DRS
p6mvhsh
28 Apr 23
Draft registration statement
12:00am
- Prev
- 1
- Next